Netherlands, Utrecht (Utrecht City Campus)


when 14 July 2014 - 18 July 2014
duration 1 week
fee EUR 1150

The course will start with the basics of pharmacoeconomics and then provide a broader insight and cover the issues described above from a governmental, industry and regulatory perspective. All lecturers have extensive experience in the field and come from universities, regulatory bodies and pharmaceutical industry. You will experience an intensive programme covering the following topics: concepts in pharmacoeconomics, pharmacoeconomics and regulatory, pharmacoeconomics and orphan drugs, the possibilities and limitations of pharmacoeconomics, experiences in HTA around the world.

Course leader

Dr. Anke Hövels and Prof. dr. Jan Raaijmakers

Target group

Postgraduates, clinicians and professionals within governments, industry, universities with a basic knowledge of epidemiology, pharmacoeconomics and an interest in benefit/risk evaluation of medicine

Course aim

This course aims to recap the basics and provide a broad perspective of the use of pharmacoeconomics in practice. The course includes a variety of subjects from views of the different stakeholders to more in depth methodological approaches, illustrated with examples and exercises.

Credits info

Certificate of Attendance

Fee info

EUR 1150: • € 1150 - Course + course materials + housing
• € 950 - Course + course materials

In combination with M7 or M8: €950,- per course (including course materials + lunches + course dinner, excluding housing). Combination fee for two courses is €1500,- (excluding housing), combination fee for all three courses combined is €1950,- (excluding housing)


Utrecht Summer School doesn't offer scholarships for this course.

Register for this course
on course website